Cargando…
Concurrent BRAF and PTEN mutations in melanoma of unknown origin presenting as a breast mass
BACKGROUND: Metastases represent a small percentage of the malignancies affecting the breast, and only 5% of melanomas originate from non-cutaneous sites. Multiple genetic aberrations have been associated with the development of melanocytic lesions, including BRAF V600E mutation. Mutations in PTEN g...
Autores principales: | Agosto-Arroyo, Emmanuel, Rosa, Marilin, Chau, Alec, Khazai, Laila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5456025/ https://www.ncbi.nlm.nih.gov/pubmed/28607685 http://dx.doi.org/10.1177/2050313X17711064 |
Ejemplares similares
-
PERK mediates resistance to BRAF inhibition in melanoma with impaired PTEN
por: Qin, Yifei, et al.
Publicado: (2021) -
Malignant Melanoma of Unknown Primary Origin Presenting as Cardiac Metastasis
por: Lee, Eun Young, et al.
Publicado: (2012) -
Notch Signaling Suppresses Melanoma Tumor Development in BRAF/Pten Mice
por: Mikheil, Dareen, et al.
Publicado: (2023) -
Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells
por: Fedorenko, Inna V., et al.
Publicado: (2015) -
BRaf(V600E) cooperates with Pten silencing to elicit metastatic melanoma
por: Dankort, David, et al.
Publicado: (2009)